Comvita Limited — Director's Dealing 2023

Oct 1, 2023

DocuSign Envelope ID: 8E66A1B6-8356-4919-BE20-E868B4D23997

==> picture [85 x 23] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Comvita Limited Date this disclosure made: 2-Oct-23 Date of last disclosure: 11-Apr-23 Director or senior manager giving disclosure Full name(s): David Robert Banfield Name of listed issuer: Comvita Limited Name of related body corporate (if applicable): N/A Position held in listed issuer: CEO and Managing Director Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Ordinary shares Class of affected quoted financial products: Performance share rights Nature of the affected relevant interest(s): Registered Holder For that relevant interest- 546,078 ordinary shares (167,742 held by David Banfield and 378,336 held on behalf of the David Number held in class before acquisition or disposal: and Joy Banfield Trust) 353,376 performance share rights 620,208 ordinary shares (167,742 held by David Banfield and 452,466 held on behalf of the David Number held in class after acquisition or disposal: and Joy Banfield Trust) 279,246 performance share rights David Banfield, Joy Banfield and Julian Donald as Current registered holder(s): trustees for the David and Joy Banfield Trust Registered holder(s) once transfers are registered: David Banfield Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: 1 Details of transactions requiring disclosure- Date of transaction: 29-Sep-23 74,130 PSR's converted to ordinary shares under Nature of transaction: the Comvita Limited Performance Share Rights Scheme Name of any other party or parties to the transaction (if known): N/A The consideration, expressed in New Zealand dollars, paid or received for the Nil acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: 74,130 ordinary shares 74,130 PSR's Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: No Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s):

Certification

I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

==> picture [98 x 37] intentionally omitted <==

2-Oct-23